A detailed history of Parcion Private Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Parcion Private Wealth LLC holds 14,497 shares of ABBV stock, worth $2.63 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
14,497
Previous 11,804 22.81%
Holding current value
$2.63 Million
Previous $2.02 Million 41.4%
% of portfolio
0.24%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $441,221 - $536,795
2,693 Added 22.81%
14,497 $2.86 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $147,050 - $171,722
950 Added 8.75%
11,804 $2.02 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $3,196 - $3,642
20 Added 0.18%
10,854 $1.98 Million
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $19,676 - $22,160
-143 Reduced 1.3%
10,834 $1.68 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $38,340 - $44,384
287 Added 2.68%
10,977 $1.64 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $7,953 - $9,159
55 Added 0.52%
10,690 $1.7 Million
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $8,455 - $9,697
-63 Reduced 0.59%
10,635 $1.43 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $15,000 - $19,070
109 Added 1.03%
10,698 $1.59 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $72,720 - $90,226
-551 Reduced 4.95%
10,589 $1.74 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $156,203 - $197,642
-1,454 Reduced 11.55%
11,140 $1.51 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $23,727 - $26,933
223 Added 1.8%
12,594 $1.38 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $2,274 - $3,043
-31 Reduced 0.25%
12,371 $1.23 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $14,383 - $21,807
223 Added 1.83%
12,402 $945,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $878,471 - $1.1 Million
12,179 New
12,179 $1.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parcion Private Wealth LLC Portfolio

Follow Parcion Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parcion Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parcion Private Wealth LLC with notifications on news.